Fig. 1From: Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing EnterobacteriaceaeTimeline of treatment and sample collection during the study. The numbers represent weeks since the baseline visit (week 0). EoT: End of treatment. Primary endpoint: sustained gastrointestinal eradication of OXA-PE at week 6 after the EoT. Secondary endpoints: decolonization of OXA-PE at the EoT and 3 weeks after the EoTBack to article page